- Home
- ACHR vs KYMR Comparison
ACHR vs KYMR Comparison
Compare ACHR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHR | KYMR |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | 1148 | N/A |
| Industry | Aerospace | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 6.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACHR | KYMR |
|---|---|---|
| Price | $6.31 | $84.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 26 |
| Target Price | $12.00 | ★ $108.04 |
| AVG Volume (30 Days) | ★ 27.6M | 747.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,211,000.00 |
| Revenue This Year | $12,475.67 | $16.05 |
| Revenue Next Year | $900.00 | $4.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.48 | $19.45 |
| 52 Week High | $14.62 | $103.00 |
Technical Indicators
Market Signals| Indicator | ACHR | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 50.87 |
| Support Level | N/A | $66.33 |
| Resistance Level | $7.55 | $95.90 |
| Average True Range (ATR) | 0.43 | 4.53 |
| MACD | -0.04 | -0.97 |
| Stochastic Oscillator | 11.52 | 26.08 |
Price Performance
Historical ComparisonAbout ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner. The company is building a platform to deliver aircraft, technologies, and services to customers world-wide across commercial and defense sectors.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.